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We have read the paper by El-Garem et al reporting the effect of Helicobacter pylori (H. pylori) 
treatment on sperm motility in infertile asthenozoospermic men.
1
 Evaluating seminal antibodies 
(IgA) to H pylori by enzyme-linked immunosorbent assay on a total of 223 men with progressive 
and nonprogressive sperm motility, authors found elevated levels of seminal H. pylori IgA antibody 
in 22 (9.8%) subjects. These cases were treated with anti-H. pylori triple therapy based on 
omeprazole, tinidazole and clarithromycin. After treatment, a significant decrease of antibody levels 
was observed in association with a significant increase in sperm motility and  normalization of 
morphology. Considering a potential antigenic mimicry mechanism, inducing an autoimmune cross-
reaction between antibody directed to bacterial antigens and β-tubulin protein of human 
spermatozoa, authors concluded that H. pylori treatment improved sperm motility suggesting the 
research of seminal antibodies to H. pylori in asthenozoospermic men.
1
  
H pylori is a Gram-negative bacterium, its niche is the stomach where can cause gastritis 
and peptic disease. Although since two decades extra-gastric manifestations have been attributed to 
this bacterium but only for a small part of these a role has been proved.
2 
Although the authors correctly reported the lack of association between serum an seminal 
IgA, a clear clinical message should be highlighted. In this study the presence of H pylori has not 
been shown because the assessment of antibodies to the bacterium in semen is not an appropriate 
test. In fact, according to International guidelines the non-invasive diagnosis of H pylori infection 
should be based on either 
13
C-Urea breath test (sensitivity 88-95% and specificity 95-100%) or 
monoclonal stool antigen test (sensitivity 94% and specificity 92%), called direct tests; as last 
resort, only validated IgG serology should be used (indirect test).
3
 Indeed, the presence of 
antibodies to H pylori could represent just a marker of previous exposure without necessarily 
indicating a current infection. In the context of interventional studies the use of a direct diagnostic 
test both prior to and after treatment is mandatory.  
Since the message highlighted in this paper
1
 could carry relevant implications in clinical 
practice, we suggest that future studies on this issue should use appropriate and validated methods 
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